A Study of the L-PPDS With Adjunctive Xalatan® Eye Drops in Subjects With OH or OAG

Clinical trial NCT01037036 · COMPLETED

Trial details

NCT number: NCT01037036
Sponsor: Mati Therapeutics Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ocular Hypertension Open-Angle Glaucoma

Start date: 2009-12-01
Primary completion: 2010-04-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.